SE436749B - Forfarande for framstellning av 2,5-dihydro-1,2-tiazino/5,6-b/indol-3-karboxamid-1,1-dioxider - Google Patents

Forfarande for framstellning av 2,5-dihydro-1,2-tiazino/5,6-b/indol-3-karboxamid-1,1-dioxider

Info

Publication number
SE436749B
SE436749B SE7714833A SE7714833A SE436749B SE 436749 B SE436749 B SE 436749B SE 7714833 A SE7714833 A SE 7714833A SE 7714833 A SE7714833 A SE 7714833A SE 436749 B SE436749 B SE 436749B
Authority
SE
Sweden
Prior art keywords
dihydro
indole
thiazino
dioxide
hydroxy
Prior art date
Application number
SE7714833A
Other languages
English (en)
Swedish (sv)
Other versions
SE7714833L (sv
Inventor
G Trummlitz
W Engel
E Seeger
W Haarmann
G Engelhardt
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of SE7714833L publication Critical patent/SE7714833L/xx
Publication of SE436749B publication Critical patent/SE436749B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7714833A 1977-02-03 1977-12-28 Forfarande for framstellning av 2,5-dihydro-1,2-tiazino/5,6-b/indol-3-karboxamid-1,1-dioxider SE436749B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772704485 DE2704485A1 (de) 1977-02-03 1977-02-03 Neue 2,5-dihydro-1,2-thiazino eckige klammer auf 5,6-b eckige klammer zu indol-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
SE7714833L SE7714833L (sv) 1978-08-04
SE436749B true SE436749B (sv) 1985-01-21

Family

ID=6000267

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714833A SE436749B (sv) 1977-02-03 1977-12-28 Forfarande for framstellning av 2,5-dihydro-1,2-tiazino/5,6-b/indol-3-karboxamid-1,1-dioxider

Country Status (35)

Country Link
US (1) US4137313A (es)
JP (1) JPS5398998A (es)
AT (3) AT355585B (es)
AU (1) AU516178B2 (es)
BE (1) BE863588A (es)
BG (1) BG36499A3 (es)
CA (1) CA1088064A (es)
CH (1) CH639389A5 (es)
CS (1) CS194195B2 (es)
DD (1) DD134767A5 (es)
DE (1) DE2704485A1 (es)
DK (1) DK150517C (es)
ES (5) ES466555A1 (es)
FI (1) FI62097C (es)
FR (1) FR2379542A1 (es)
GB (1) GB1569238A (es)
GR (1) GR64418B (es)
HK (1) HK71383A (es)
HU (1) HU175550B (es)
IE (1) IE46185B1 (es)
IL (1) IL53948A (es)
IT (1) IT1105151B (es)
LU (1) LU78974A1 (es)
MY (1) MY8400283A (es)
NL (1) NL7801183A (es)
NO (1) NO148490C (es)
NZ (1) NZ186374A (es)
PH (1) PH13882A (es)
PL (1) PL109705B1 (es)
PT (1) PT67607B (es)
SE (1) SE436749B (es)
SG (1) SG48083G (es)
SU (1) SU654173A3 (es)
YU (1) YU24478A (es)
ZA (1) ZA78630B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
GR80576B (en) * 1983-10-17 1984-11-29 Fujisawa Pharmaceutical Co Thiazine derivatives, process for preparation thereof and pharmaceutical composition comprising the same
US4683306A (en) * 1984-07-13 1987-07-28 Yuhan Corporation Co., Ltd. Process for the preparation of 3,4-dihydro-2-substituted-2H-1,2-thiazine-carboxylic acid 1,1-dioxide derivatives
US6407124B1 (en) 1998-06-18 2002-06-18 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588693A5 (es) * 1973-12-10 1977-06-15 Image Analysing Computers Ltd
IL47877A (en) * 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
AT345847B (de) * 1974-11-08 1978-10-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer 4-hydroxy-2h- naphtho- (2,1-e)-1,2-thiazin-3-carboxamid-1,1-dioxid und deren salze

Also Published As

Publication number Publication date
ES469113A1 (es) 1978-11-16
ATA269679A (de) 1979-08-15
NZ186374A (en) 1980-03-05
IL53948A0 (en) 1978-04-30
JPS5398998A (en) 1978-08-29
DK150517C (da) 1987-10-19
PL204401A1 (pl) 1979-04-09
LU78974A1 (de) 1979-05-25
ZA78630B (en) 1979-10-31
BG36499A3 (en) 1984-11-15
YU24478A (en) 1982-10-31
US4137313A (en) 1979-01-30
FI62097C (fi) 1982-11-10
IE46185B1 (en) 1983-03-23
ATA11178A (de) 1979-08-15
PT67607B (de) 1980-03-03
SE7714833L (sv) 1978-08-04
ES469111A1 (es) 1978-11-16
CA1088064A (en) 1980-10-21
NO148490B (no) 1983-07-11
ES469110A1 (es) 1978-11-16
HU175550B (hu) 1980-08-28
IT7847828A0 (it) 1978-01-27
AT355585B (de) 1980-03-10
BE863588A (fr) 1978-08-02
FR2379542A1 (fr) 1978-09-01
PT67607A (de) 1978-03-01
PL109705B1 (en) 1980-06-30
GB1569238A (en) 1980-06-11
MY8400283A (en) 1984-12-31
SG48083G (en) 1984-07-27
IL53948A (en) 1980-10-26
GR64418B (en) 1980-03-21
ES466555A1 (es) 1978-10-01
NL7801183A (nl) 1978-08-07
HK71383A (en) 1983-12-30
AT355591B (de) 1980-03-10
FI780324A (fi) 1978-08-04
DE2704485A1 (de) 1978-08-10
AT355590B (de) 1980-03-10
IT1105151B (it) 1985-10-28
DK150517B (da) 1987-03-16
NO780370L (no) 1978-08-04
PH13882A (en) 1980-10-27
CS194195B2 (en) 1979-11-30
SU654173A3 (ru) 1979-03-25
AU3293178A (en) 1979-08-09
ES469112A1 (es) 1978-11-16
ATA269579A (de) 1979-08-15
FR2379542B1 (es) 1982-12-03
CH639389A5 (de) 1983-11-15
DD134767A5 (de) 1979-03-21
DK48478A (da) 1978-08-04
NO148490C (no) 1983-10-19
AU516178B2 (en) 1981-05-21
JPS6111235B2 (es) 1986-04-01
FI62097B (fi) 1982-07-30
IE780246L (en) 1978-08-03

Similar Documents

Publication Publication Date Title
US3591584A (en) Benzothiazine dioxides
HU211557A9 (en) Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
RU2125569C1 (ru) Производные полизамещенных 2-амидо-4-фенилтиазолов, способ их получения, промежуточные соединения синтеза и фармацевтическая композиция на их основе
JPH04217981A (ja) １，８−ナフチリジン−２−オン誘導体
CN112409294B (zh) 苯并噻嗪酮衍生物及其制备方法与作为抗结核药物的应用
CN104059060B (zh) 一种5‑(1h‑吲哚‑3‑亚甲基)‑1,3‑噻唑烷‑4‑酮类衍生物及其合成方法和应用
KR20130046436A (ko) 안드로겐 수용체 길항제, 항암제로서 사이클릭 n,n''-다이아릴티오우레아 및 n,n''-다이아릴우레아, 이의 제조방법 및 이의 용도
JPH01249769A (ja) 向精神性ヘテロビシクロアルキルピペラジン誘導体
PL202763B1 (pl) Pochodne 8, 8a-dihydro-indeno [1,2-d] tiazolu oraz pochodne 8, 8a-dihydro-indeno [1,2-d] tiazolu do zastosowania jako lek
US3530142A (en) N - (2 - benzoxazolyl or -benzothiazolyl)-aminomethylene-carboxylic acid esters
SE436749B (sv) Forfarande for framstellning av 2,5-dihydro-1,2-tiazino/5,6-b/indol-3-karboxamid-1,1-dioxider
CA2091688A1 (en) Antiproliferative substituted naphthalene compounds
FI60011C (fi) Foerfarande foer framstaellning av antiflogistiska och blodplaettars aggregering haemmande 4-hydroxi-2h-nafto/2,1-e/-tiazin-3-karboxamid-1,1-dioxider
KR920003927B1 (ko) 헤테로사이클릭구아니딘 5ht_3 길항물질
SE465270B (sv) Antipsykotiska ringkondenserade pyridinylpiperazinderivat, foerfarande foer framstaellning daerav samt farmaceutisk beredning
CN106946896B (zh) 呋喃并[2,3-d]嘧啶-4-胺衍生物
CA2127318A1 (en) Imidazole compounds and use thereof
JP2726999B2 (ja) イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
US4748280A (en) Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
SE434944B (sv) 5-(klorofenyl)-6h-1,3,4-tiadiazin-2-aminer
CN114634503B (zh) 含吲哚生物碱杂环取代-1,3-噻唑烷酮类衍生物及其制备方法和用途
JPH0114235B2 (es)
JPS6239583A (ja) ベンゾジオキソ−ル誘導体及びその製造法
CN114634504B (zh) 取代吲哚酮-偶氮链-3-取代-噻唑烷酮类化合物及其制备方法和用途
Jaiash et al. Design, synthesis and biological evaluation of new pyrroloazepines with potential and selective antitumor activity

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7714833-6

Effective date: 19880927

Format of ref document f/p: F